10/21/2026
Total Joint Orthopedics has secured up to $11 million in growth financing from Wells Fargo to expand our inventory and instrument sets, sales channel coverage, and next-generation Aurum® and hip pipeline. This capital lets us move faster on what we do best: simplifying joint replacement through Efficiency by Design®.
Here's where we're putting it to work:
■ Inventory and instrument expansion: more implants and instrument sets for new and existing surgeon customers in hospitals and ASCs
■ Sales channel expansion: adding and strengthening distribution partners in targeted markets
■ Next-generation Aurum® Technology: advancing porous and revision designs as part of our multi-year plan to eliminate cobalt chrome in orthopedic implants
■ Hip portfolio expansion: developing a next-generation hip stem to complement the Platform® Hip System portfolio
■ Advanced manufacturing: expanding additive manufacturing with supply partners to shorten lead times and strengthen supply chain resilience
We're building on real momentum: 55,000+ implants placed, 42,000+ of them Klassic® Knees, and 32% of our 2026 procedures in ASCs.
"This financing marks a turning point for TJO," said CEO Erin Hofmann.
Thank you to the surgeons, distribution partners, team members, and shareholders who got us here. We're just getting started.
Next up: come see us at AAHKS 2026, November 5–8 in Grapevine, Texas.
Read the full press release: https://www.tjoinc.com/post/growth-financing-to-accelerate-commercial-expansion-and-product-innovation